Jubilant Of India Cleared For Takeover Of Canada’s Draxis
This article was originally published in PharmAsia News
Executive Summary
India's Jubilant Organosys received clearance from shareholders of Draxis Health to acquire the Canadian biotech. Draxis said 99 percent of the shareholders approved the deal, but the merger must still be approved by the Quebec Superior Court. The move would give Jubilant entry into the North American market for radiopharmaceuticals. (Click here for more